This country profile provides an overview of the United Republic of Tanzania’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Treatment coverage
Elephantiasis
15%
Blinding trachoma
41%
Intestinal worms
36%
Bilharzia
65%
River blindness
83%
15.07 million
people received treatment in Tanzania in 2019
12.01 million
people did not receive treatment in Tanzania in 2019
Elephantiasis
Treatment coverage decreased from 91% in 2018 to 15% in 2019.
People needing treatment
7.95m
People receiving treatment
1.16m
Blinding trachoma
Treatment coverage increased from 40% in 2018 to 41% in 2019.
People needing treatment
2.87m
People receiving treatment
1.18m
Intestinal worms
Treatment decreased from 60% in 2018 to 36% in 2019.
Pre-sch and school-aged children needing treatment
18.79m
Pre-school and school-aged children receiving treatment
6.77m
Bilharzia
Treatment coverage decreased from 100% in 2018 to 65% in 2019.
School-aged children needing treatment
6.58m
School-aged children receiving treatment
4.26m
River blindness
Treatment coverage increased from 81% in 2018 to 83% in 2019.
People needing treatment
6.48m
People receiving treatment
5.34m
The 
ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Tanzania.